Skip to main content
. 2009 May;23(5):348–352. doi: 10.1155/2009/180840

Figure 1).

Figure 1)

Proportion of patients with infliximab maintenance response and those off corticosteroids. Maintenance of clinical response to infliximab was defined according to the physician’s global assessment and the patient being off corticosteroids (solid bar). Loss of response was defined as an increase in Crohn’s disease-related symptoms with documented initiation of corticosteroids; Crohn’s disease-related surgery for disease activity; termination of infliximab prescription due to loss of effect; termination of infliximab due to adverse event(s); or termination of infliximab for any other reason (open bar)